title: Hot Topics in Primary Care: Individualizing Dual Therapy for Type 2 Diabetes Mellitus.
abstract: While many advances in the management of patients with type 2 diabetes mellitus (T2DM) have occurred over the past decade, nearly half of patients with diabetes still have a glycated hemoglobin (HbA1c) above the target of 7.0%.
authors.affiliation: Associate Director, Family Medicine Residency Program, Abington Memorial Hospital, Abington, PA, USA. .|Professor of Family and Community Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
authors.forename: Neil S
authors.initials: NS
authors.lastname: Skolnik
authors.affiliation: Abington Hospital - Jefferson Health, Family Medicine Office, Jenkintown, PA, USA.
authors.forename: Florence
authors.initials: F
authors.lastname: Jaffa
authors.affiliation: Abington Hospital - Jefferson Health, Family Medicine Office, Jenkintown, PA, USA.
authors.forename: Yan
authors.initials: Y
authors.lastname: Kiriakov
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D018802:Patient-Centered Care / Q000592:standards*; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000592:standards*
chemical_list: D006442:Glycated Hemoglobin